Accelerate Diagnostics
AXDX
#11223
Rank
A$1.23 M
Marketcap
A$0.04866
Share price
0.00%
Change (1 day)
-97.03%
Change (1 year)

Earnings for Accelerate Diagnostics (AXDX)

Earnings in 2024 (TTM): -A$55.8 Million

According to Accelerate Diagnostics's latest financial reports the company's current earnings are A$11.69 Million. , an increase over its 2023 earnings that were of -A$75.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Accelerate Diagnostics from 1998 to 2024

Annual earnings

Year Earnings Change
2024 -A$52.95 Million-30.23%
2023 -A$75.89 Million-10.11%
2022 -A$84.43 Million-5.02%
2021 -A$88.89 Million-0.87%
2020 -A$89.67 Million-10.7%
2019 -A$0.11 Billion-10.05%
2018 -A$0.12 Billion22.77%
2017 -A$90.93 Million-4%
2016 -A$94.72 Million47.64%
2015 -A$64.16 Million42.74%
2014 -A$44.95 Million105.26%
2013 -A$21.9 Million
2011 -A$1.7 Million-182.9%
2010 A$2.04 M-219.16%
2009 -A$1.72 Million6.65%
2008 -A$1.62 Million-40.67%
2007 -A$2.72 Million14.69%
2006 -A$2.37 Million399.94%
2005 -A$0.48 Million
2001 -A$1.65 Million-52.29%
2000 -A$3.45 Million53.4%
1999 -A$2.25 Million-282.93%
1998 A$1.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.92 B-20,743.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$2.14 B-4,143.79%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$0.67 B-1,382.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
A$55.95 M-205.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-A$0.23 Billion 328.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$0.50 B-1,047.16%๐Ÿ‡บ๐Ÿ‡ธ USA